Jan Erik Alenfall

Jan Erik Alenfall

Chief Executive Officer presso Callipa AB

62 anni
Health Technology

Profilo

Jan Erik Alenfall is currently the Managing Director & Director at Callipa AB.
Previously, he worked as the Chief Executive Officer & Director at DermaGen AB, Head-Research at Probi AB, Manager-International Clinical Research at Ferring Pharmaceuticals A, Associate-Clinical Research at Pharmacia AB, Head-Clinical & Preclinical Research at Trettiosjucorp AB, Manager-International Clinical Research at Rechon Life Science AB, and Head-Clinical & Preclinical Research at SkyePharma AB.
He also served as the Chief Scientific Officer at Follicum AB from 2013 to 2021.

Posizioni attive di Jan Erik Alenfall

SocietàPosizioneInizio
Callipa AB Chief Executive Officer -
Tutte le posizioni attive di Jan Erik Alenfall

Precedenti posizioni note di Jan Erik Alenfall

SocietàPosizioneFine
FOLLICUM AB (PUBL) Chief Executive Officer 06/04/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Jan Erik Alenfall

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jan Erik Alenfall

Relazioni

13

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
PROBI AB

Health Technology

Aziende private8

Health Technology

Pharmacia AB

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Callipa AB

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Jan Erik Alenfall